WallStreetZenWallStreetZen

NASDAQ: AEHR
Aehr Test Systems Stock Forecast, Predictions & Price Target

Analyst price target for AEHR

Based on 1 analyst offering 12 month price targets for Aehr Test Systems.
Min Forecast
$12.00+15.83%
Avg Forecast
$12.00+15.83%
Max Forecast
$12.00+15.83%

Should I buy or sell AEHR stock?

Based on 1 analyst offering ratings for Aehr Test Systems.
Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their AEHR stock forecasts and price targets.

AEHR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-26

1 of 1

Forecast return on equity

Is AEHR forecast to generate an efficient return?

Forecast return on assets

Is AEHR forecast to generate an efficient return on assets?

AEHR revenue forecast

What is AEHR's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$65.0M-9.58%
Avg 2 year Forecast
$70.6M-1.79%
AEHR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

AEHR revenue growth forecast

How is AEHR forecast to perform vs Semiconductor Equipment & Materials companies and vs the US market?
Company
-9.58%
Industry
3.56%
Market
13.2%
AEHR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AEHR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AEHR vs Semiconductor Equipment Stocks

TickerPricePrice TargetUp/downsideConsensus
AEHR$10.36$12.00+15.83%Hold
TGAN$4.79N/AN/A
ATOM$5.70N/AN/A
INTT$11.09N/AN/A
AXTI$2.77$5.38+94.04%Strong Buy

Aehr Test Systems Stock Forecast FAQ

Is Aehr Test Systems Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: AEHR) stock is to Hold AEHR stock.

Out of 1 analyst, 0 (0%) are recommending AEHR as a Strong Buy, 0 (0%) are recommending AEHR as a Buy, 1 (100%) are recommending AEHR as a Hold, 0 (0%) are recommending AEHR as a Sell, and 0 (0%) are recommending AEHR as a Strong Sell.

If you're new to stock investing, here's how to buy Aehr Test Systems stock.

What is AEHR's revenue growth forecast for 2024-2025?

(NASDAQ: AEHR) Aehr Test Systems's forecast annual revenue growth rate of -9.58% is not forecast to beat the US Semiconductor Equipment & Materials industry's average forecast revenue growth rate of 3.56%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.2%.

Aehr Test Systems's revenue in 2024 is $71,887,000.On average, 1 Wall Street analysts forecast AEHR's revenue for 2024 to be $1,879,457,385, with the lowest AEHR revenue forecast at $1,879,457,385, and the highest AEHR revenue forecast at $1,879,457,385.

In 2025, AEHR is forecast to generate $2,041,379,867 in revenue, with the lowest revenue forecast at $2,041,379,867 and the highest revenue forecast at $2,041,379,867.

What is AEHR's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: AEHR) forecast ROA is N/A, which is lower than the forecast US Semiconductor Equipment & Materials industry average of 19.27%.

What is AEHR's Price Target?

According to 1 Wall Street analyst that have issued a 1 year AEHR price target, the average AEHR price target is $12.00, with the highest AEHR stock price forecast at $12.00 and the lowest AEHR stock price forecast at $12.00.

The Wall Street analyst predicted that Aehr Test Systems's share price could reach $12.00 by Mar 26, 2025. The average Aehr Test Systems stock price prediction forecasts a potential upside of 15.83% from the current AEHR share price of $10.36.

What is AEHR's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: AEHR) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.